ZEMANOVÁ, M., Vlastimil ŠČUDLA, Zdeněk ADAM, E. GREGORA, Luděk POUR, J. MINAŘÍK, P. PAVLÍČEK, T. PIKA and Jaroslav BAČOVSKÝ. Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma. Neoplasma. Bratislava: Slovak Academic Press, Ltd., 2008, vol. 55, No 4, p. 345-349. ISSN 0028-2685.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma
Name in Czech Režim nízkodávkovaného thalidomidu u léčby relabovaného nebo refrakterního mnohočetného myelomu
Authors ZEMANOVÁ, M. (203 Czech Republic), Vlastimil ŠČUDLA (203 Czech Republic), Zdeněk ADAM (203 Czech Republic, guarantor), E. GREGORA (203 Czech Republic), Luděk POUR (203 Czech Republic), J. MINAŘÍK (203 Czech Republic), P. PAVLÍČEK (203 Czech Republic), T. PIKA (203 Czech Republic) and Jaroslav BAČOVSKÝ (203 Czech Republic).
Edition Neoplasma, Bratislava, Slovak Academic Press, Ltd. 2008, 0028-2685.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.179
RIV identification code RIV/00216224:14110/08:00035959
Organization unit Faculty of Medicine
UT WoS 000257128400012
Keywords (in Czech) mnohočetný myelom; thalidomid
Keywords in English multiple myeloma; resistance to therapy; thalidomide; cyclophosphamide; dexamethasone
Tags cyclophosphamide, dexamethasone, multiple myeloma, resistance to therapy, Thalidomide
Tags International impact, Reviewed
Changed by Changed by: Mgr. Anna Potáčová, Ph.D., učo 44190. Changed: 24/6/2009 11:15.
Abstract
Thalidomide has been estimated as a useful drug in therapy of refractory or relapsed multiple myeloma. Recently, several studies have shown very good results in therapy combination of thalidomide, cyclophosphamide and dexamethasone, but still high doses of thalidomide associated with serious adverse events have been used. In our study, we performed low-dose thalidomide regimens; the aim of this study was to verify the effect and to assess their toxicity.
Abstract (in Czech)
V této studii jsou popsány režimy léčby v kombinaci s thalidomidem a zhodnocení jejich toxicity.
PrintDisplayed: 8/10/2024 07:30